ADVFN US – Market Content Editor

  • Iovance Raises 2026 Revenue Guidance to $410 Million-$420 Million

    Iovance Raises 2026 Revenue Guidance to $410 Million-$420 Million

    Iovance Biotherapeutics (NASDAQ:IOVA) raised its full-year 2026 total revenue guidance to between $410 million and $420 million, compared with its previous forecast of $350 million to $370 million. The midpoint of the revised range is $55 million above the midpoint of the previous guidance and represents an increase of approximately 15%. Iovance said the new…

  • EVgo Previews 750kW EV Charging System Ahead of Planned 2027 Rollout

    EVgo Previews 750kW EV Charging System Ahead of Planned 2027 Rollout

    EVgo Inc. (NASDAQ:EVGO) has previewed a next-generation electric vehicle charging system capable of delivering up to 750kW of charging power, with deployment expected to begin in 2027. Design, development and testing of the system are underway at EVgo’s Innovation Lab in El Segundo, California, with Delta Electronics supporting the co-development process. EVgo expects to unveil…

  • uniQure Shares Fall 64% After 48-Month AMT-130 Huntington’s Disease Trial Update

    uniQure Shares Fall 64% After 48-Month AMT-130 Huntington’s Disease Trial Update

    uniQure N.V. (NASDAQ:QURE) shares fell 64% on Tuesday after the gene therapy developer reported updated 48-month data for ifezuntirgene inilparvovec, or AMT-130, its experimental treatment for Huntington’s disease. The high-dose group continued to show a slower rate of disease progression compared with an external control group, but the result on the composite Unified Huntington’s Disease…

  • ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update

    ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update

    ClearPoint Neuro (NASDAQ:CLPT) shares fell 24% on Tuesday following updated clinical trial results from partner uniQure N.V. (NASDAQ:QURE) for its experimental Huntington’s disease gene therapy. uniQure shares declined 55% after the company reported updated data for ifezuntirgene inilparvovec, also known as AMT-130. The treatment did not achieve statistical significance on a primary clinical measure at…

  • Alaska Air Group Sets 2030 Growth Targets at Investor Day

    Alaska Air Group Sets 2030 Growth Targets at Investor Day

    Alaska Air Group (NYSE:ALK) outlined the next phase of its Alaska Accelerate strategic plan at its 2026 Investor Day in Seattle, including targets for premium travel, international routes, loyalty, cargo and fleet expansion. The company described the next stage of the plan as an “activation” phase following integration work associated with its acquisition of Hawaiian…

  • Bell Canada and Cisco Sign MOU to Develop Sovereign AI Infrastructure Offering

    Bell Canada and Cisco Sign MOU to Develop Sovereign AI Infrastructure Offering

    Bell Canada (BCE) and Cisco (NASDAQ:CSCO) have signed a memorandum of understanding to collaborate on a sovereign artificial intelligence infrastructure offering for customers in Canada. The proposed offering will combine Bell’s Canadian data centre, network and operational capabilities with Cisco’s AI, security, observability, infrastructure monitoring and management technologies, including its Sovereign Critical Infrastructure portfolio. The…

  • Voyager Technologies Shares Rise 6% After Anduril Partnership Announcement

    Voyager Technologies Shares Rise 6% After Anduril Partnership Announcement

    Voyager Technologies (NYSE:VOYG) shares rose 6% on Tuesday after the company announced a strategic partnership with Anduril Industries covering the development and production of weapons systems and missile defence technologies. The agreement formalises an existing collaboration between the two companies across multiple weapons programmes, including several initiatives identified as priorities by the US Department of…

  • Cboe Shares Rise 5% After Extending S&P 500 Licensing Agreement Through 2051

    Cboe Shares Rise 5% After Extending S&P 500 Licensing Agreement Through 2051

    Cboe Global Markets (AMEX:CBOE) shares rose 5% after the company announced a 25-year extension of its exclusive licensing agreement with S&P Dow Jones Indices, continuing the relationship through 2051. The agreement maintains Cboe’s exclusive rights to offer trading in its S&P 500 Index (SPX) options and provides scope for the companies to develop additional products…

  • FuelCell Energy Shares Rise After Oppenheimer Initiates Coverage With Outperform Rating

    FuelCell Energy Shares Rise After Oppenheimer Initiates Coverage With Outperform Rating

    FuelCell Energy (NASDAQ:FCEL) shares rose 9% in premarket trading on Tuesday after Oppenheimer initiated coverage of the company with an Outperform rating and a $24 price target. Analyst Colin Rusch cited FuelCell Energy’s exposure to demand for on-site power generation from the expanding data centre market, describing the company as a “differentiated provider” of firm,…

  • US Futures Edge Higher as Oil Prices and Treasury Yields Pull Back: Dow Jones, S&P, Nasdaq, Wall Street

    US Futures Edge Higher as Oil Prices and Treasury Yields Pull Back: Dow Jones, S&P, Nasdaq, Wall Street

    US stock futures pointed to a modestly higher open on Tuesday, with a decline in crude oil prices and a pullback in Treasury yields following losses for the major Wall Street indexes in the previous session. US crude oil futures fell more than 2%, reversing part of Monday’s increase. Oil prices declined despite limited progress…